| THE ORENCIA COPAY PROGRAM Bristol-Myers Squibb Company
85038498 14 May 2010 | on 23 Aug 2019 | Administering a pharmacy copay reimbursement program for use in connec... Class 035 Class 035 Advertising, Business & Retail Services Color is not claimed as a feature of the mark. | | | CUSTOMERS @ CENTER Bristol-Myers Squibb Company
85407135 25 Aug 2011 | on 28 Dec 2015 | Educational services, namely, developing and conducting training cours... Class 016 Class 016 Paper Goods and Printed Material Educational services, namely, developing and conducting training courses in the field of health care and pharmaceuticals and distribution of training material in connection therewith Class 035 Class 035 Advertising, Business & Retail Services Educational services, namely, developing and conducting training courses in the field of health care and pharmaceuticals and distribution of training material in connection therewith Class 041 Education and Entertainment Services Printed matter, namely, information materials in the nature of newsletters, pamphlets and brochures in the field of health care and pharmaceuticals
Class 044 Medical, Beauty & Agricultural Services CUSTOMERS AT CENTER | | | MY POST TRANSPLANT NETWORK Bristol-Myers Squibb Company
85343047 10 Jun 2011 | on 13 Jul 2015 | Educational services, namely, conducting classes, seminars and worksho... Class 016 Class 016 Paper Goods and Printed Material "POST TRANSPLANT NETWORK" Class 041 Class 041 Education and Entertainment Services Educational services, namely, conducting classes, seminars and workshops regarding pharmaceutical preparations for the prevention of solid organ transplant rejection | | | COMMAND COMBINATION REGIMENS AND NS5A DEVELOPMENT IN HEPATITIS C Bristol-Myers Squibb Company
85354235 23 Jun 2011 | on 02 Mar 2015 | Medical and scientific research, namely, conducting clinical trials re... Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use, namely, relating to combination of regimens that affect NS5A development in the treatment of hepatitis C | | | PICOT PLUS Bristol-Myers Squibb Company
85318803 12 May 2011 | on 12 Jan 2015 | Pharmaceutical preparations for human use, namely, antacids and analge... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use, namely, antacids and analgesics | | | ANGIOCEPT ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
85327083 23 May 2011 | on 09 Sep 2013 | Biotechnology and pharmaceutical products, namely, therapeutic protein... Class 005 Class 005 Pharmaceutical Products Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | | ANVIL ANALYZING NS5A-BASED COMBINATION ANTIVIRAL TREATMENTS FOR HCV Bristol-Myers Squibb Company
85354242 23 Jun 2011 | on 26 Aug 2013 | Medical and scientific research, namely, conducting clinical trials re... Class 042 Class 042 Computer & Software Services & Scientific Services Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use, namely, relating to analysis of NS5A-based combination antiviral treatments for the hepatitis C virus | | | ZYMOGENETICS ZymoGenetics, Inc.
85319968 13 May 2011 | on 05 Aug 2013 | Scientific services, namely, discovery, technical analysis and process... Class 042 Class 042 Computer & Software Services & Scientific Services The mark consists of "ZYMOGENETICS" and a straight line over the top of the words. | | | ADNECTIN ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
85327078 23 May 2011 | on 11 Mar 2013 | Biotechnology and pharmaceutical products, namely, therapeutic protein... Class 005 Class 005 Pharmaceutical Products Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies | | | MULPLICITI Bristol-Myers Squibb Company
85358377 28 Jun 2011 | on 06 Jun 2012 | Pharmaceutical preparations for human use,Pharmaceutical preparations ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use | | 
